NorthRock Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

NorthRock Partners’s Portfolio BCAT Stock Details BCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$301K	Buy	+21,281	New	+$313K	﹤0.01%	521

Other funds holding BCAT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NorthRock Partners's BCAT Position: Q1 2026 in Review

NorthRock Partners opened a new position in BlackRock Capital Allocation Term Trust (BCAT) in Q1 2026: 21,281 shares worth $301K. The stake represents ﹤0.01% of the portfolio and ranks #521 among its holdings.

100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

NorthRock Partners held 21,281 shares of BlackRock Capital Allocation Term Trust worth $301K as of Q1 2026.
BlackRock Capital Allocation Term Trust was a new NorthRock Partners position in Q1 2026.
BlackRock Capital Allocation Term Trust made up ﹤0.01% of NorthRock Partners's portfolio in Q1 2026, its #521 holding.
100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.